Randialic acid A (Pomolic acid) is a pentacyclic triterpene isolated from Euscaphis japonica (Tunb.). Randialic acid A (Pomolic acid) inhibits tumor cells growth and induces cell apoptosis. Randialic acid A (Pomolic acid) has a potential for the treatment of prostate cancer (PC)^[2]. IC50 & Target: IC50: apoptosis^[1] In Vitro: Randialic acid A (Pomolic acid) induces apoptosis of GBM cells as demonstrated by DNA fragmentation.  Pomolic acid-induced apoptosis is dependent on reactive oxygen species (ROS) production. It also induces uncoupling of mitochondria membrane potential and activation of caspase-3 and -9^[2].